warnings
Warnings
Walgreens Moisturizing Ultra Fine Mist with Aloe
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Walgreens Moisturizing Ultra Fine Mist with Aloe
- Generic name
- 0.05% OXYMETAZOLINE
- Manufacturer
- Walgreens Company
- Product type
- HUMAN OTC DRUG
- SPL set ID
- aad01028-cbe0-4c10-adbc-d157bfa5af09
- SPL ID
- dbead0b6-6e70-4304-abf9-f610db983f46
- Version
- 2
- Effective date
- 2024-07-16
- Source export date
- 2026-10-12
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/f40eac55ff4c5d55c3d8bbc5766ea7e21e4196960cfb4703b96a406b491c0cd5/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:33:26
| Harmonized routes |
|---|
| NASAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M012 | openfda.application_number | |
| brand name | Walgreens Moisturizing Ultra Fine Mist with Aloe | openfda.brand_name | |
| generic name | 0.05% OXYMETAZOLINE | openfda.generic_name | |
| manufacturer name | Walgreens Company | openfda.manufacturer_name | |
| ndc | package | 0363-2355-15 | openfda.package_ndc |
| ndc | product | 0363-2355 | openfda.product_ndc |
| ndc11 | package | 00363235515 | derived:openfda.package_ndc |
| rxcui | 1000990 | openfda.rxcui | |
| spl id | dbead0b6-6e70-4304-abf9-f610db983f46 | id | |
| spl set id | aad01028-cbe0-4c10-adbc-d157bfa5af09 | set_id | |
| unii | K89MJ0S5VY | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.